Health data

Oxford Science Enterprises Strengthens Investment Teams with Two Senior Appointments

Retrieved on: 
Friday, February 11, 2022
List of life sciences, University of Oxford, Patient, EIR, Operating partner, Health policy, CEO, NHS, Government, Data science, Exact sciences, HDR, Company, Budesonide, Johnson Health Tech, University, Leadership, McKinsey & Company, Health data, Pharma, Biotechnology, Survival, Food, Master of Engineering, Board of directors, Growth, Research, Dexamethasone, Drug discovery, COVID-19, Discovery, Management, Pharmaceutical industry

As Operating Partner, Craig will work across Oxford Science Enterprises' life sciences portfolio and apply his extensive operating and scientific expertise to support the growth and development of early and late-stage companies.

Key Points: 
  • As Operating Partner, Craig will work across Oxford Science Enterprises' life sciences portfolio and apply his extensive operating and scientific expertise to support the growth and development of early and late-stage companies.
  • Alexis Dormandy, CEO Oxford Science Enterprises, said:"I am delighted to welcome both Craig and Caroline to the team.
  • The appointments of Craig and Caroline, two seasoned executives with impressive track records, builds on the recent strengthening of our senior leadership team.
  • We are Oxford Science Enterprises, the Science Business Builder.

Oxford Science Enterprises Strengthens Investment Teams with Two Senior Appointments

Retrieved on: 
Friday, February 11, 2022
List of life sciences, University of Oxford, Patient, EIR, Operating partner, Health policy, CEO, NHS, Government, Data science, Exact sciences, HDR, Company, CSO, Budesonide, Johnson Health Tech, University, Leadership, McKinsey & Company, Health data, Pharma, Biotechnology, Survival, Food, Master of Engineering, Board of directors, Growth, Research, Dexamethasone, Drug discovery, COVID-19, Discovery, Management, Pharmaceutical industry, Entrepreneurship

OXFORD, England, Feb. 11, 2022 /PRNewswire/ -- Oxford Science Enterprises, the Science Business Builder and preferred intellectual property partner of the University of Oxford, today announces the appointment of Craig Fox PhD as Operating Partner, Life Sciences and Caroline Cake MBA, MEng, as Entrepreneur in Residence, Health Tech.

Key Points: 
  • As Operating Partner, Craig will work across Oxford Science Enterprises' life sciences portfolio and apply his extensive operating and scientific expertise to support the growth and development of early and late-stage companies.
  • Alexis Dormandy, CEO Oxford Science Enterprises, said:"I am delighted to welcome both Craig and Caroline to the team.
  • The appointments of Craig and Caroline, two seasoned executives with impressive track records, builds on the recent strengthening of our senior leadership team.
  • We are Oxford Science Enterprises, the Science Business Builder.

NYAM and NYC Health Department Drive Health Equity Research Through Unique Collaboration

Retrieved on: 
Tuesday, December 14, 2021
Health data, Mental Hygiene, Government, Member, Health equity, Police, Veni, vidi, vici, Child, Mindy Thompson Fullilove, Social media, COVID-19, Urban Health Resource Centre, Journal, New York Academy of Medicine, NYAM, Fellows, Research, Maternal health, Knowledge, Cluster analysis, Health department, Mother, Journal of Urban Health, Policy, GLOBE, Michelle McMurry-Heath, Partnership, Asthma, Publication, Pharmaceutical industry, Hospital, Health, MD

HD4NYC promotes collaborative health equity research while advancing the careers of early- and mid-career researchers.

Key Points: 
  • HD4NYC promotes collaborative health equity research while advancing the careers of early- and mid-career researchers.
  • Four original research articles are included in the Journal of Urban Health Special Section as well as an Overview Paper authored by NYAM, the Health Department, and HD4NYC senior mentors (co-leads).
  • The original research articles reflect the collaboration of HD4NYCs academic and Health Department researchers.
  • Health Data for New York City Overview: Advancing Health Equity through Policy-Relevant Collaborative Research.

Healthcare Analytics Market to Reach $96.90 Bn, Globally, by 2030 at 15.3% CAGR: Allied Market Research

Retrieved on: 
Monday, September 6, 2021
Articles, Business intelligence, Computing, Formal sciences, Data analysis, Analytics, Big data, Prescriptive analytics, Electronic health record, Predictive analytics, Health data, Draft:Big data analytics

PORTLAND, Ore., Sept. 6, 2021 /PRNewswire/ -- Allied Market Research published a report, titled, "Healthcare Analytics Market by Application (Financial Analysis, Operational & Administrative Analysis and Clinical Analysis), Component (Hardware, Software and Services), Deployment Model (On-Premise and On-Demand), End User (Healthcare Payers, Healthcare Providers and Others), and Type (Descriptive Analytics, Predictive Analytics, and Prescriptive Analytics): Global Opportunity Analysis and Industry Forecast, 2021–2030." According to the report published by Allied Market Research, the global healthcare analytics market was estimated at $23.51 billion in 2020 and is expected to hit $96.90 billion by 2030, registering a CAGR of 15.3% from 2021 to 2030.

Key Points: 
  • PORTLAND, Ore., Sept. 6, 2021 /PRNewswire/ -- Allied Market Research published a report, titled, "Healthcare Analytics Market by Application (Financial Analysis, Operational & Administrative Analysis and Clinical Analysis), Component (Hardware, Software and Services), Deployment Model (On-Premise and On-Demand), End User (Healthcare Payers, Healthcare Providers and Others), and Type (Descriptive Analytics, Predictive Analytics, and Prescriptive Analytics): Global Opportunity Analysis and Industry Forecast, 20212030."
  • According to the report published by Allied Market Research, the global healthcare analytics market was estimated at $23.51 billion in 2020 and is expected to hit $96.90 billion by 2030, registering a CAGR of 15.3% from 2021 to 2030.
  • Based on application, the financial analysis segment contributed to the largest share in 2020, holding more than two-fifths of the global healthcare analytics market.
  • Growing government healthcare regulations to reduce the rising healthcare costs and increasing regulatory requirements propel the need for healthcare analytics in the region.

The Valens Company Enters Agreement with Harvest One to Manufacture and Distribute Leading Cannabis-Infused Topical Brand LivRelief™

Retrieved on: 
Wednesday, July 28, 2021
Ancient Romans, Marketing, Cannabis, Cannabis smoking, Entheogens, Herbalism, Brand, Valens, Business

("Harvest One") to become the white label manufacturer and provincial sales partner of cannabis-infused topicals for their leading brand LivRelief .

Key Points: 
  • ("Harvest One") to become the white label manufacturer and provincial sales partner of cannabis-infused topicals for their leading brand LivRelief .
  • Together, Harvest One and The Valens Company will seek to expand distribution and increase consumer awareness and brand loyalty across Canada.
  • The Valens Company is a leading manufacturer of cannabis products with a mission to bring the benefits of cannabis to the world.
  • Nothing herein should be construed as either an offer to sell or a solicitation to buy or sell securities of The Valens Company.

Massachusetts eHealth Collaborative Fulfills Mission; Completes Final Dissolution

Retrieved on: 
Tuesday, July 20, 2021
Health informatics, Waltham, Massachusetts, EHR, Health data, Electronic health records

WALTHAM, Mass., July 20, 2021 /PRNewswire-PRWeb/ -- The Massachusetts eHealth Collaborative (MAeHC), a national leader in health information technology for over 15 years, has been dissolved after distributing its remaining assets to six local public charities.

Key Points: 
  • WALTHAM, Mass., July 20, 2021 /PRNewswire-PRWeb/ -- The Massachusetts eHealth Collaborative (MAeHC), a national leader in health information technology for over 15 years, has been dissolved after distributing its remaining assets to six local public charities.
  • "Now, with our work completed, and our mission fulfilled, it's time to pass the torch to a new generation of HIT innovators."
  • Finally, in order to identify Massachusetts public charities to receive its remaining assets, the MAeHC Board formed a Grant Program Selection Subcommittee to conduct an RFP process.
  • Massachusetts Health Data Consortium will design, test, and complete a documented prototype for Electronic Prior Authorization integrated with the EHR.

Diameter Health Selected as Amazon HealthLake Connector Partner

Retrieved on: 
Thursday, July 15, 2021
Computing, Technology, JSON, Fast Healthcare Interoperability Resources, Cloud infrastructure, Amazon Web Services, Amazon, Health data

FARMINGTON, Conn., July 15, 2021 /PRNewswire/ -- Diameter Health , a fast-growing leader in health data interoperability and optimization, today announced that it has been selected by Amazon Web Services, Inc. (AWS) as a Connector Partner for Amazon HealthLake , a HIPAA-eligibleservice that enables healthcare organizations to store, transform, query, and analyze health data at scale.

Key Points: 
  • FARMINGTON, Conn., July 15, 2021 /PRNewswire/ -- Diameter Health , a fast-growing leader in health data interoperability and optimization, today announced that it has been selected by Amazon Web Services, Inc. (AWS) as a Connector Partner for Amazon HealthLake , a HIPAA-eligibleservice that enables healthcare organizations to store, transform, query, and analyze health data at scale.
  • Once customer data is normalized, optimized and converted to FHIR by Diameter Health, it can be stored and analyzed via Amazon HealthLake.
  • "Diameter Health is excited to have been named a select Connector Partner for Amazon HealthLake to deliver FHIR-enabled and optimized data to AWS customers," said Eric Rosow, Chief Executive Officer, Diameter Health.
  • "With Diameter Health as an Amazon HealthLake Connector Partner, customers who do not already have data in the FHIR format can leverage Diameter's offeringsto transform existing healthcare data into FHIR format and move it to Amazon HealthLake.

Ciitizen in Palo Alto Selects Healthcare Information Technology Industry Expert as Vice President of Health Information Exchange (HIE) Strategy

Retrieved on: 
Tuesday, July 13, 2021
General Health, Health, Data management, Technology, Software, Health, Health informatics, Articles, Health information exchange, Interoperability, Health information technology, Health data, Health care

As an integral member of the Ciitizen executive team, Glenns long history and experience with HIEs position Ciitizen to grow existing and new relationships with leading health information organizations.

Key Points: 
  • As an integral member of the Ciitizen executive team, Glenns long history and experience with HIEs position Ciitizen to grow existing and new relationships with leading health information organizations.
  • Glenn has spent the past 35 years working in healthcare information technology and towards the goal of greater information access.
  • The Axolotl User Group, which gathered annually for more than ten years, served as the foundation for the Strategic Health Information Exchange Collaborative (SHIEC).
  • Ciitizens focus on building relationships with HIEs will drive greater interoperability and access to health data across the industry.

Aetion and Cegedim Health Data Announce Long-Term Partnership to Expand Real-World Evidence Research in Europe

Retrieved on: 
Monday, July 12, 2021
Data security, Data protection, Health informatics, Articles, Health, Cegedim, The Health Improvement Network, Anonymity, Privacy, Data anonymization, Health data, Information privacy

NEW YORK, July 12, 2021 /PRNewswire/ -- Today, Aetion and Cegedim Health Data announced an expanded, 3-year partnership that facilitates access to Cegedim Health Data's anonymized real-world data through the Aetion Evidence Platform (AEP).

Key Points: 
  • NEW YORK, July 12, 2021 /PRNewswire/ -- Today, Aetion and Cegedim Health Data announced an expanded, 3-year partnership that facilitates access to Cegedim Health Data's anonymized real-world data through the Aetion Evidence Platform (AEP).
  • Cegedim Health Data 's The Health Improvement Network ( THIN ) database currently covers the United Kingdom, France, Spain, Italy, Belgium, and Romania, with plans to add data from Germany.
  • "The Aetion-Cegedim Health Data partnership advances access to pan-European data sources for real-world evidence research, and enables us to help our customers navigate data privacy regulations and the heterogeneity of data across countries," said Carolyn Magill, CEO of Aetion.
  • Cegedim Health Data provides anonymized Real-World Data and Evidence (RWD-E) platforms and advanced studies to drive cutting-edge improvements in patient outcomes in the interests of public health.

Health Gorilla Successfully Completes SOC 2 Type 2 Certification

Retrieved on: 
Thursday, June 24, 2021
Health informatics, Health, Articles, Medical record, Health care, Health data, Digital health

SOC 2 Type 2 certification is an expansion on the SOC 2 Type 1 certification Health Gorilla already had in place.

Key Points: 
  • SOC 2 Type 2 certification is an expansion on the SOC 2 Type 1 certification Health Gorilla already had in place.
  • "Earning the SOC 2 certification attests that Health Gorilla is committed to protecting patient data against unauthorized access and assures our customers that cybersecurity, access controls, and data governance are key components of Health Gorilla's full suite of clinical data services."
  • Founded in 2014, Health Gorilla is a secure interoperability solution that enables the entire health care ecosystem patients, payers, providers, digital health solutions, and labs to seamlessly share health data and aggregate each patient's full clinical history in one place.
  • Headquartered in Silicon Valley, Health Gorilla works with health care organizations around the world, helping them gather the clinical data they need to deliver the best and most appropriate care for their patients.